Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura D'Erasmo

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
Atherosclerosis|October 17, 2022
ANGPTL3 deficiency associates with the expansion of regulatory T cells with reduced lipid contentAlessandra Pinzon Grimaldos, Ilenia Pacella, Simone Bini, et al.
Journal of the American Heart Association|October 18, 2023
Real-World Effectiveness of PCSK9 Inhibitors in Reducing LDL-C in Patients With Familial Hypercholesterolemia in Italy: A Retrospective Cohort Study Based on the AIFA Monitoring RegistriesMarcello Arca, Simone Celant, Pier Paolo Olimpieri, et al.
Heart Failure Clinics|November 15, 2021
New Frontiers in the Treatment of Homozygous Familial HypercholesterolemiaArturo Cesaro, Fabio Fimiani, Felice Gragnano, et al.
Journal of Clinical Lipidology|June 11, 2025
Lomitapide-induced fatty liver is a reversible condition: Evidence from a case of familial chylomicronemia syndromeDaniele Tramontano, Michele di Martino, Francesco Baratta, et al.
Journal of Translational Medicine|November 26, 2025
Lipid deprivation amplifies type I IFN responses in monocytes through prenylation: insights from familial combined hypolipidemia type 2Alessandra Pinzon Grimaldos, Ilenia Pacella, Tiziano Giacomelli, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 1, 2019
Metabolomic Signature of Angiopoietin-Like Protein 3 Deficiency in Fasting and Postprandial StateEmmi Tikkanen, Ilenia Minicocci, Jenni Hällfors, et al.
Atherosclerosis|December 21, 2024
Sex-related differences in response to lomitapide in HoFH: A subanalysis of the Pan-European Lomitapide retrospective observational studyChiara Pavanello, Patrizia Suppressa, Sofia Castiglione, et al.
European Journal of Preventive Cardiology|February 20, 2024
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN RegistryLaura D'Erasmo, Simone Bini, Manuela Casula, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 9, 2019
Lysosomal acid lipase activity and liver fibrosis in the clinical continuum of non-alcoholic fatty liver diseaseFrancesco Baratta, Daniele Pastori, Giulia Tozzi, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 26, 2022
Differential effects of bariatric surgery on plasma levels of ANGPTL3 and ANGPTL4Simone Bini, Laura D'Erasmo, Brenno Astiarraga, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
Atherosclerosis|October 17, 2022
ANGPTL3 deficiency associates with the expansion of regulatory T cells with reduced lipid contentAlessandra Pinzon Grimaldos, Ilenia Pacella, Simone Bini, et al.
Journal of the American Heart Association|October 18, 2023
Real-World Effectiveness of PCSK9 Inhibitors in Reducing LDL-C in Patients With Familial Hypercholesterolemia in Italy: A Retrospective Cohort Study Based on the AIFA Monitoring RegistriesMarcello Arca, Simone Celant, Pier Paolo Olimpieri, et al.
Heart Failure Clinics|November 15, 2021
New Frontiers in the Treatment of Homozygous Familial HypercholesterolemiaArturo Cesaro, Fabio Fimiani, Felice Gragnano, et al.
Journal of Clinical Lipidology|June 11, 2025
Lomitapide-induced fatty liver is a reversible condition: Evidence from a case of familial chylomicronemia syndromeDaniele Tramontano, Michele di Martino, Francesco Baratta, et al.
Journal of Translational Medicine|November 26, 2025
Lipid deprivation amplifies type I IFN responses in monocytes through prenylation: insights from familial combined hypolipidemia type 2Alessandra Pinzon Grimaldos, Ilenia Pacella, Tiziano Giacomelli, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 1, 2019
Metabolomic Signature of Angiopoietin-Like Protein 3 Deficiency in Fasting and Postprandial StateEmmi Tikkanen, Ilenia Minicocci, Jenni Hällfors, et al.
Atherosclerosis|December 21, 2024
Sex-related differences in response to lomitapide in HoFH: A subanalysis of the Pan-European Lomitapide retrospective observational studyChiara Pavanello, Patrizia Suppressa, Sofia Castiglione, et al.
European Journal of Preventive Cardiology|February 20, 2024
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN RegistryLaura D'Erasmo, Simone Bini, Manuela Casula, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 9, 2019
Lysosomal acid lipase activity and liver fibrosis in the clinical continuum of non-alcoholic fatty liver diseaseFrancesco Baratta, Daniele Pastori, Giulia Tozzi, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 26, 2022
Differential effects of bariatric surgery on plasma levels of ANGPTL3 and ANGPTL4Simone Bini, Laura D'Erasmo, Brenno Astiarraga, et al.
Pageof 8